Cargando…
Overview of REJOIN: A Clinical Trial to Use Exercise to Relieve Joint Pain in Older Breast Cancer Survivors
Aromatase Inhibitors (AIs) are recommended for survival in hormone-sensitive breast cancer survivors, yet are underutilized, especially in older survivors. Joint pain is a prevalent AI-related symptom that is associated with low adherence. The aims for this randomized clinical trial (n=76) are to: 1...
Autores principales: | Bluethmann, Shirley, Truica, Cristina, Olsen, Nancy, Sciamanna, Christopher, Klepin, Heidi, Chinchilli, Vernon, Schmitz, Kathryn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7741719/ http://dx.doi.org/10.1093/geroni/igaa057.2239 |
Ejemplares similares
-
Adapting an Evidence-based Physical Activity Program for The REJOIN Trial for Older Breast Cancer Survivors
por: Bluethmann, Shirley, et al.
Publicado: (2021) -
Spain rejoins CERN
por: CERN Press Office. Geneva
Publicado: (1982) -
FROM BIG DATA TO COMMUNITY SETTINGS: HOW CAN EXERCISE IMPROVE HEALTH OUTCOMES IN OLDER CANCER SURVIVORS?
por: Bluethmann, Shirley M, et al.
Publicado: (2019) -
A Stochastic Model of DNA Fragments Rejoining
por: Li, Yongfeng, et al.
Publicado: (2012) -
Spain rejoins CERN: lifting of Spanish flag
por: CERN PhotoLab
Publicado: (1983)